Searched for
PFIZER PATENT VIOLATION
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bidPfizer sued Metsera and Novo Nordisk, alleging Metsera breached its merger agreement by deeming Novo's $8.5 billion bid superior. Pfizer se...- German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patentA German court has ruled that Pfizer and BioNTech violated Moderna's COVID-19 vaccine patent. The court in Duesseldorf stated that Pfizer a...
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
- Patents not real barrier in access to healthcare: PfizerThe company said it is bullish about the branded generics biz & is ‘open to partnerships with local cos that will help it ‘provide high-qua...
- Pfizer complains about India’s intellectual property regime againIn a letter, US pharma giant Pfizer has urged the Indian government to “shift from using destructive IP policy as an access strategy”.
- Indian patent law doesn't discriminate against US companies: IPAIndian Pharma Alliance (IPA) writes to Roy Waldron after he slammed country's IP policy as protectionist and discriminatory.
- Indian Pharmaceutical Alliance slams US over charges on Indian patent lawIf a country feels that a provision or policy of another nation discriminates against its companies, it can challenge that under WTO's disp...
- Only 3% of patents filed by MNC pharma firms under dispute: StudyPatent experts say few drugmakers are challenging frivolous drug patents and the Indian patent office is actually liberal in granting paten...
- Generic business may hit drug exports of Indian firms like Cipla and NatcoIndia exported medicines worth $13.2 billion last fiscal and the government plans to double it to $25 billion by March 2014.
- Wyeth makes $960 mn claims on Protonix patent case: Sun PharmaSun Pharma said US-based Wyeth Pharma has sought damages worth $960 mn related to their ongoing patent dispute over generic version of Prot...
- Ranbaxy gets USFDA nod to sell LipitorThe approval marks an end to months of uncertainty surrounding approval of the drug which could earn Ranbaxy over $500 mn. Stock quote
- Ranbaxy set to get USFDA nod for Lipitor generic launch"The FDA has been very positive about Ranbaxy's intent to launch the product and we are working towards meeting the launch timeline", a per...
- Watson starts selling generic Lipitor in US, Ranbaxy mumUS-based Watson Pharmaceuticals said it has launched in US market the generic version of cholesterol lowering drug Lipitor following the ex...
- FDI curbs in pharma could deter MNCs: Kewal Handa, Pfizer India MDIndia's attempts to check foreign investment in pharma and expand drug pricing control could force multinationals to exit the country.
- Pfizer, Dr Reddy's settle patent suit over LipitorPfizer's Lipitor is the world's largest-selling drug, which generated about $7 billion in sales last year in the US alone.
- Ranbaxy, USFDA in settlement talks over $1 billion fine: ReportSettling the issue is of immense importance to Ranbaxy as it is the first firm to file an abbreviated new drug application to launch a gene...
- Non-compliance with disclosure norms on patents may bring trouble for pharma companiesSeveral global drugmakers, including Pfizer, Roche and Bayer, have not met full mandatory disclosures of their patented medicines in India,...
- Pfizer charges Sun with another patent violationA legal battle between Pfizer and Sun Pharmaceutical has escalated.
- MNC pharma firms told to launch latest drugs in IndiaThe government has asked MNC pharma companies to launch latest drugs in India.
- Ranbaxy wins on two additional patents in NorwayIn yet another boost to India's biggest drug maker Ranbaxy Laboratories, a Norwegian court has ruled in its favour in the patent litigation...
Load More
